Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-124898
Filing Date
2021-04-21
Accepted
2021-04-21 16:45:48
Documents
10

Document Format Files

Seq Description Document Type Size
1 424(B)(5) d125110d424b5.htm 424B5 663690
2 GRAPHIC g125110g03t84.jpg GRAPHIC 24887
3 GRAPHIC g125110g12c92.jpg GRAPHIC 23552
4 GRAPHIC g125110g26k16.jpg GRAPHIC 33983
5 GRAPHIC g125110g43q85.jpg GRAPHIC 22968
6 GRAPHIC g125110g47d98.jpg GRAPHIC 22730
7 GRAPHIC g125110g67j59.jpg GRAPHIC 22988
8 GRAPHIC g125110g77j38.jpg GRAPHIC 23824
9 GRAPHIC g125110g80u99.jpg GRAPHIC 22761
10 GRAPHIC g125110g97u73.jpg GRAPHIC 23238
  Complete submission text file 0001193125-21-124898.txt   945953
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255340 | Film No.: 21842066
SIC: 2834 Pharmaceutical Preparations